Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Mol Cancer Res. 2014 Sep 24;13(2):330–338. doi: 10.1158/1541-7786.MCR-14-0251

Figure 2. LincRNA-RoR is overexpressed in TNBC where it serves as competitive endogenous RNA for miR-145.

Figure 2

A, lincRNA-RoR expression in breast tumor tissues as measured by qRT-PCR. B, lincRNA-RoR expression in breast cancer cell lines. C, micRoRNA-145 response element in lincRNA-RoR as predicted by MiRanda 4.0 algorithm. D, miR-145 expression analysis following lincRNA-RoR overexpression in HEK-293T cells. E, lincRNA-RoR expression analysis following miR-145 overexpression in HEK-293T cells. F, Luciferase reporter assay for lincRNA-RoR in HEK-293T cells overexpressing miR-145. G, miR-145 expression analysis in MDA-MB-231 breast cancer cells following lincRNA-RoR overexpression. H, Fluorescent images of MDA-MB-231 cells stably infected with lincRNA-RoRshRNA. I, Expression analysis of lincRNA-RoR and miR-145 following lincRNA-RoR knockdown via qRT-PCR.* p< 0.05